Pt and Pt‐group transition metal 0D vacancy ordered halide perovskites: A review
EcoMat · 2024-11 · 6 (11)
DOI: 10.1002/eom2.12492 ↗Kurz gefasst
Fachartikel in der Zeitschrift EcoMat, online erschienen am 16.10.2024. Verfasst von Huilong Liu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Lead halide perovskites (LHPs), have attracted considerable attention across various applications owing to their exceptional optoelectronic properties. However, the main challenge hindering the broad adoption of lead halide perovskites lies in their stability and toxicity. In this review, we summarize the outstanding properties of platinum (Pt) halide perovskites, with a particular focus on the stability and applications of Cs 2 PtI 6 and its derivatives. Cs 2 PtI 6 has shown promising efficiency for photovoltaic devices, as well as photoelectrochemical water splitting with stable behavior in acid or basic conditions. Cs 2 PtI 6 also shows promise in gas sensing and thermoelectric devices. The emergence of 2D Pt (II) halide perovskites opens up new avenues for environmentally friendly materials for photonic and optoelectronic devices like room temperature phosphoresce and triplet‐triplet annihilation (TTA) based up‐conversion. image
Förderung
- National Science Foundation
Zitieren
APA
Liu, H., & Bansal, S. (2024). Pt and Pt‐group transition metal 0D vacancy ordered halide perovskites: A review. EcoMat, 6(11). https://doi.org/10.1002/eom2.12492
Vancouver
Liu H, Bansal S. Pt and Pt‐group transition metal 0D vacancy ordered halide perovskites: A review. EcoMat. 2024;6(11). doi:10.1002/eom2.12492
BibTeX
@article{Liu2024,
author = {Liu, Huilong and Bansal, Shubhra},
title = {Pt and Pt‐group transition metal 0D vacancy ordered halide perovskites: A review},
journal = {EcoMat},
year = {2024},
volume = {6},
number = {11},
doi = {10.1002/eom2.12492}
}
EUVIMED